Literature DB >> 31668289

A shared decision-making tool for individuals living with complete androgen insensitivity syndrome.

Erica M Weidler1, Arlene Baratz2, Miriam Muscarella3, S Janett Hernandez1, Kathleen van Leeuwen4.   

Abstract

Reports exist regarding a gradual approach to the care of patients with differences of sexual development. Each patient and family have different values and styles of learning that have to be taken into account. The goals of care should include education about the condition, counseling of the patient and family, and a complete outlining of treatment options. Motivated by a call from the 2010 Health Reform Law for the use of shared decision-making tools and the emphasis placed on these issues by the DSD Consensus Statement, we sought to develop and implement such tools for the DSD population.1-3 Thus, we developed an organized checklist for providers to share with a patients and families affected by CAIS, beginning with the initial visit. The development of the document enlisted input from physicians, clinical coordinator, advocacy groups and affected individuals. It allows providers to explain the process of care and develop a plan for delivery of that care over multiple visits spanning six months or more. The checklist is divided into five sections: 1) An overview addressing how much information is desired and in what manner the patient prefers to obtain information; 2) A preferred words list so that the patient can choose nomenclature that is most comfortable; 3) A list of topics to review over the course of multiple visits; 4) A list of questions to be answered by the providers or other resources over time, and; 5) A list of concerns to be addressed before surgical intervention is considered. An organized approach to long-term delivery of compassionate care and accurate information can be facilitated for patients with CAIS by the use of a shared decision-making checklist. Documentation of the care delivery process can stimulate referral to peer support and promote fully informed consent for treatment decisions. The use of the checklist should encourage trust in the provider, as well as aid in identifying and addressing stressors for the patient and family. The checklist will be updated and revised as new treatments and advanced technology emerges.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complete androgen insensitivity syndrome; Decision support tool; Differences of sex development; Disorders of sex development; Shared decision-making

Mesh:

Year:  2019        PMID: 31668289      PMCID: PMC7208826          DOI: 10.1016/j.sempedsurg.2019.150844

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  30 in total

1.  Testicular feminization syndrome and associated gonadal tumors in Denmark.

Authors:  S Bangsbøll; I Qvist; P E Lebech; M Lewinsky
Journal:  Acta Obstet Gynecol Scand       Date:  1992-01       Impact factor: 3.636

Review 2.  Disorders of Sex Development/Intersex: Gaps in Psychosocial Care for Children.

Authors:  Michelle M Ernst; Lih-Mei Liao; Arlene B Baratz; David E Sandberg
Journal:  Pediatrics       Date:  2018-08       Impact factor: 7.124

3.  Parental Decisional Regret after Primary Distal Hypospadias Repair: Family and Surgery Variables, and Repair Outcomes.

Authors:  Filippo Ghidini; Sasa Sekulovic; Marco Castagnetti
Journal:  J Urol       Date:  2015-10-27       Impact factor: 7.450

4.  Genotype versus phenotype in families with androgen insensitivity syndrome.

Authors:  A L Boehmer; O Brinkmann; H Brüggenwirth; C van Assendelft; B J Otten; M C Verleun-Mooijman; M F Niermeijer; H G Brunner; C W Rouwé; J J Waelkens; W Oostdijk; W J Kleijer; T H van der Kwast; M A de Vroede; S L Drop
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

Review 5.  Molecular basis of androgen insensitivity.

Authors:  A O Brinkmann
Journal:  Mol Cell Endocrinol       Date:  2001-06-20       Impact factor: 4.102

6.  Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trial.

Authors:  Wiebke Birnbaum; Louise Marshall; Ralf Werner; Alexandra Kulle; Paul-Martin Holterhus; Katharina Rall; Birgit Köhler; Annette Richter-Unruh; Michaela F Hartmann; Stefan A Wudy; Matthias K Auer; Anke Lux; Siegfried Kropf; Olaf Hiort
Journal:  Lancet Diabetes Endocrinol       Date:  2018-07-31       Impact factor: 32.069

7.  A shared decision-making communication training program for physicians treating fibromyalgia patients: effects of a randomized controlled trial.

Authors:  Christiane Bieber; Knut Georg Müller; Klaus Blumenstiel; Achim Hochlehnert; Stefanie Wilke; Mechthild Hartmann; Wolfgang Eich
Journal:  J Psychosom Res       Date:  2008-01       Impact factor: 3.006

8.  Coping With Diverse Sex Development: Treatment Experiences and Psychosocial Support During Childhood and Adolescence and Adult Well-Being.

Authors:  Katinka Schweizer; Franziska Brunner; Benjamin Gedrose; Christina Handford; Hertha Richter-Appelt
Journal:  J Pediatr Psychol       Date:  2017-06-01

9.  Does Patient-centered Care Change Genital Surgery Decisions? The Strategic Use of Clinical Uncertainty in Disorders of Sex Development Clinics.

Authors:  Stefan Timmermans; Ashelee Yang; Melissa Gardner; Catherine E Keegan; Beverly M Yashar; Patricia Y Fechner; Margarett Shnorhavorian; Eric Vilain; Laura A Siminoff; David E Sandberg
Journal:  J Health Soc Behav       Date:  2018-10-10

Review 10.  Different Clinical Presentations and Management in Complete Androgen Insensitivity Syndrome (CAIS).

Authors:  Lucia Lanciotti; Marta Cofini; Alberto Leonardi; Mirko Bertozzi; Laura Penta; Susanna Esposito
Journal:  Int J Environ Res Public Health       Date:  2019-04-09       Impact factor: 3.390

View more
  3 in total

1.  Evolving indications for surgical intervention in patients with differences/disorders of sex development: Implications of deferred reconstruction.

Authors:  Erica M Weidler; Gwen Grimsby; Erin M Garvey; Noor Zwayne; Reeti Chawla; Janett Hernandez; Timothy Schaub; Richard Rink; Kathleen van Leeuwen
Journal:  Semin Pediatr Surg       Date:  2020-05-17       Impact factor: 2.754

2.  Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

Authors:  E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus
Journal:  Int J Transgend Health       Date:  2022-09-06

3.  Diagnosis of DSD in Children-Development of New Tools for a Structured Diagnostic and Information Management Program within the Empower-DSD Study.

Authors:  Katja Wechsung; Louise Marshall; Martina Jürgensen; Uta Neumann
Journal:  J Clin Med       Date:  2022-07-03       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.